Lantern Pharma (LTRN) Earnings Date & Reports

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LTRN is expected to report earnings to fall 1.85% to -52 cents per share on August 06

Lantern Pharma LTRN Stock Earnings Reports

Q2'25

Est.

$-0.53

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.14

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.08

The last earnings report on March 27 showed earnings per share of -54 cents, beating the estimate of -58 cents. With 47.83K shares outstanding, the current market capitalization sits at 44.33M.

View a ticker or compare two or three

Compare

LTRN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LTRN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1920 McKinney Avenue

Phone

+1 972 277-1136

Employees

Web

https://www.lanternpharma.com